Clinical trial Recruiting at 1 site Observational Ages 18 to 38 Women only

Gene profiling of cumulus cells after CAPA‑IVM

Official title: Transcriptomic Profiling of Cumulus Cells From CAPA-IVM Cycles in Women With PCOS: A Prospective Pilot Study

Run by Mỹ Đức Hospital · NCT07197255 · Data updated 2026-11-12

This pilot will test whether gene patterns in cumulus cells collected after CAPA‑IVM can help predict egg and embryo quality for women with PCOS undergoing CAPA‑IVM.

Quick facts

Study typeObservational
Ages18 Years to 38 Years
SexWomen only
Enrollment10 (estimated)
SponsorMỹ Đức Hospital
Academic / other
Locations1 site (Ho Chi Minh City)
StatusRecruiting
StartedOctober 16, 2025
Main results expectedJanuary 30, 2026
Study endsMarch 30, 2026
Registry record updatedNovember 21, 2025
Trial IDNCT07197255 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–38 with PCOS by Rotterdam criteria, BMI ≤32 kg/m2, AMH ≥4 ng/mL and AFC ≥24 who are scheduled for CAPA‑IVM are ideal candidates.

Probably not a fit

Women without PCOS, with low ovarian reserve (AMH <4 ng/mL or AFC <24), those using surgically retrieved sperm, or those not undergoing CAPA‑IVM are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort at My Duc Hospital will enroll women with PCOS undergoing CAPA‑IVM and collect cumulus cells from individual cumulus–oocyte complexes following a single‑culture CAPA‑IVM protocol. RNA sequencing will be performed using low‑input methods and analyzed with differential expression tools (DESeq2) and pathway analyses such as Gene Ontology and Ingenuity. The molecular profiles of cumulus cells will be correlated with embryology outcomes including fertilization, day‑3 cleavage, and blastocyst formation. The study aims to identify transcriptomic signatures that could serve as non‑invasive biomarkers of oocyte competence to inform embryo selection.

Why it matters

Potential benefit: If successful, this approach could provide a non‑invasive biomarker from cumulus cells to help select the best oocytes and embryos and potentially improve IVF success for women with PCOS.

How similar studies have gone: CAPA‑IVM has been linked to improved oocyte maturation and live births, and prior studies have shown correlations between cumulus cell gene expression and oocyte quality, but reliable transcriptomic predictors of embryo outcomes are still preliminary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women 18-38 years
* BMI =\< 32kg/m2
* Diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam 2003 criteria, meet at least 2 of the following 3 features: (1) Oligo-ovulation or anovulation. (2) Clinical and/or biochemical signs of hyperandrogenism (3) Polycystic ovarian morphology on ultrasound.
* Indicated for CAPA-IVM treatment.
* Serum AMH ≥ 4 ng/mL (28.57 pmol/L).
* Antral follicle count (AFC) ≥ 24 follicles in both ovaries at the time of CAPA-IVM indication.
* Signed informed consent to participate in the study.

Exclusion Criteria:

* Retrieved sperm from surgical procedures
* Previous IVF cycle with total immature oocytes

Where it's running

  • My Duc Hospital
    Ho Chi Minh City, Vietnam
    Recruiting

Study contacts

  • Principal investigator: Lan N Vương, PhD, MD — University of Medicine and Pharmacy at Ho Chi Minh City
  • Study coordinator: Huy H Pham, MSc.
  • Email: huy.ph@myduchospital.vn
  • Phone: +84966145510

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.